{"id":8451,"date":"2015-07-01T08:20:18","date_gmt":"2015-07-01T11:20:18","guid":{"rendered":"https:\/\/www.infobioquimica.com\/new\/?p=8451"},"modified":"2016-04-22T13:38:34","modified_gmt":"2016-04-22T16:38:34","slug":"entrevista-con-el-dr-jose-antonio-lopez-martin-espana-inmunovigilancia-del-sistema-inmune-en-el-cancer","status":"publish","type":"post","link":"https:\/\/www.infobioquimica.com\/new\/2015\/07\/01\/entrevista-con-el-dr-jose-antonio-lopez-martin-espana-inmunovigilancia-del-sistema-inmune-en-el-cancer\/","title":{"rendered":"Entrevista con el Dr. Jos\u00e9 Antonio L\u00f3pez Mart\u00edn (Espa\u00f1a): Inmunovigilancia del Sistema Inmune en el c\u00e1ncer"},"content":{"rendered":"

El Dr. Jos\u00e9 Antonio L\u00f3pez Mart\u00edn es responsable de la Unidad de Melanoma, Sarcomas y Estudios Cl\u00ednicos en Fase Precoz del Servicio de Oncolog\u00eda M\u00e9dica del Hospital 12 de Octubre de Madrid, Espa\u00f1a. El Dr. L\u00f3pez Mart\u00edn es Presidente de G\u00c9TICA (Grupo Espa\u00f1ol de Terapias Inmuno-Biol\u00f3gicas en C\u00e1ncer) una asociaci\u00f3n multidisciplinar sin fines de lucro formada por especialistas en inmunolog\u00eda, oncolog\u00eda m\u00e9dica, oncolog\u00eda radioter\u00e1pica, bi\u00f3logos, y abierta a cualquier otra disciplina que quiera participar en el conocimiento y optimizaci\u00f3n de la inmunoterapia en c\u00e1ncer.<\/p>\n

El Dr. L\u00f3pez Mart\u00edn abordar\u00e1 el tema de la inmunovigilancia del sistema inmune en el c\u00e1ncer.<\/p>\n

Primera Parte:<\/p>\n

Segunda Parte:<\/p>\nhttps:\/\/www.infobioquimica.com\/new\/wp-content\/uploads\/2016\/04\/lopezmartin2.mp3<\/a><\/audio>\n

\u00a0<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

El Dr. L\u00f3pez Mart\u00edn abordar\u00e1 el tema de la inmunovigilancia del sistema inmune en el c\u00e1ncer. <\/p>\n","protected":false},"author":1,"featured_media":8455,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"twitterCardType":"","cardImageID":0,"cardImage":"","cardTitle":"","cardDesc":"","cardImageAlt":"","cardPlayer":"","cardPlayerWidth":0,"cardPlayerHeight":0,"cardPlayerStream":"","cardPlayerCodec":"","footnotes":""},"categories":[7,2,705],"tags":[446,8346,2210,8352,6949,436,8348,8350,8344,3296],"class_list":{"0":"post-8451","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","6":"hentry","7":"category-entrevistas","8":"category-radio","10":"tag-cancer","12":"tag-inmunologia","13":"tag-inmunoterapia","14":"tag-inmunovigilancia","15":"tag-melanoma","16":"tag-oncologia-medica","17":"tag-oncologia-radioterapica","18":"tag-sarcomas","19":"tag-sistema-inmune"},"acf":[],"_links":{"self":[{"href":"https:\/\/www.infobioquimica.com\/new\/wp-json\/wp\/v2\/posts\/8451","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.infobioquimica.com\/new\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.infobioquimica.com\/new\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.infobioquimica.com\/new\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.infobioquimica.com\/new\/wp-json\/wp\/v2\/comments?post=8451"}],"version-history":[{"count":1,"href":"https:\/\/www.infobioquimica.com\/new\/wp-json\/wp\/v2\/posts\/8451\/revisions"}],"predecessor-version":[{"id":8457,"href":"https:\/\/www.infobioquimica.com\/new\/wp-json\/wp\/v2\/posts\/8451\/revisions\/8457"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.infobioquimica.com\/new\/wp-json\/wp\/v2\/media\/8455"}],"wp:attachment":[{"href":"https:\/\/www.infobioquimica.com\/new\/wp-json\/wp\/v2\/media?parent=8451"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.infobioquimica.com\/new\/wp-json\/wp\/v2\/categories?post=8451"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.infobioquimica.com\/new\/wp-json\/wp\/v2\/tags?post=8451"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}